TABLE 2.
Body weight and serum total cholesterol at baseline and percentage change from baseline at 12 and 24 mo1
| n | Baseline | Δ at 12 mo, % | Δ at 24 mo, % | ||||
|---|---|---|---|---|---|---|---|
| Body weight,2 kg | P change3 | P trend3 | P ANCOVA4 | ||||
| Soy | 42 | 86.9 (82.1, 89.9) | 1.4 (0.2, 2.5) | 2.6 (1.1, 4.0) | <0.001 | <0.001 | 0.488 |
| Placebo | 38 | 90.0 (85.0, 95.1) | 2.8 (1.4, 4.3) | 2.8 (1.4, 4.3) | <0.001 | <0.001 | |
| Total cholesterol,5 mg/dL | P difference6 | P ANCOVA4 | |||||
| Soy | 29 | 196.9 (186.1, 207.7) | NA | 2.0 (–2.2, 6.2) | 0.351 | 0.316 | |
| Placebo | 18 | 200.5 (186.8, 218.2) | NA | 0.7 (–3.9, 5.4) | 0.904 |
1
Values are means (95% CIs). NA, not available.
2
Only subjects with complete data on body weight at baseline, 12 mo, and 24 mo and age and height at baseline are included in this analysis.
3
One-way repeated-measures ANOVA of change over time.
4
ANCOVA for difference in percentage change from baseline between the 2 treatments at 24 mo, with age, height, and weight at baseline as covariates.
5
Only subjects not on cholesterol-lowering medication (self-reported) at any time during the study and with complete data on cholesterol at baseline, 12 mo, and 24 mo and age and height at baseline are included.
6
Two-sided paired t test.